1. Dendrimers: synthesis, applications, and properties;Abbasi;Nano. Res. Lett.,2014
2. Evolving guidelines for intravitreous injections;Aiello;Retina-the Journal of Retinal and Vitreous Diseases,2004
3. Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma;Akopian;J. Clin. Invest.,2017
4. U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension;Allergan,2019
5. Allergan Receives FDA Approval for DURYSTA (Bimatoprost Implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to Lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients;Allergan,2020